Showing results (371-380 of 725) with videos related to
Sort By:
Pageof 73
The American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R BrunnerHospital Practice (Office Ed.)|August 15, 1990
The renin-angiotensin system in hypertension: an updateH R BrunnerAmerican Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R BrunnerAmerican Journal of Hypertension|June 2, 1998
Endothelin inhibition as a biologic target for treating hypertensionH R BrunnerThe Journal of Clinical Investigation|November 1, 1978
Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolismC S Liang, H GavrasRevue Medicale Suisse|February 9, 2006
[Antihypertensive therapy: who should be treated and to which target?]B Waeber, M BurnierRevue Medicale Suisse|March 16, 2007
[Arterial hypertension. Factors favoring long-term compliance with therapy]B Waeber, F FeihlRevue Medicale Suisse|October 4, 2012
[Are all diuretics equal for the treatment of hypertensive patients?]B Waeber, F FeihlCirculation|April 1, 1991
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and IIY Christen, B Waeber, J Nussberger, et al.Revue Medicale Suisse|March 19, 2005
[Hypertension. Arterial pressure in the acute phase of cerebrovascular accidents]B Waeber, J BogousslavskyPageof 73